Professor Juliana Chung-Ngor Chan

Juliana Chung-Ngor Chan

Professor Juliana Chung-Ngor Chan is the Chair Professor of Medicine and Therapeutics and the Founding Director of the Hong Kong Institute of Diabetes and Obesity at The Chinese University of Hong Kong. As an endocrinologist and clinician scientist, she found the Asia Diabetes Foundation as the Chief Executive Officer and the GemVCare as the Director, a biotech company specialised in genetic evaluation and management of diabetes.

Professor Chan grew up in Hong Kong and received her MBChB and MD from the University of Liverpool, United Kingdom. She is an accredited specialist in endocrinology and clinical pharmacology both in the United Kingdom and in Hong Kong, and a recipient of The International Diabetes Epidemiology Group Peter Bennett Award, The Xiaoren Pan Distinguished Research Award for Epidemiology of Diabetes in Asia, and The China Medical Women’s Association Science and Technology Award.

Professor Chan established the first and foremost Hong Kong Diabetes Register to characterise the clinical course and genetic associations of diabetes in 1995; and curated the most innovative web-based Joint Asia Diabetes Evaluation (JADE®) Programme in 2007 to combine clinical technology along with a validated diabetes care model in promoting personalised diabetes care to reduce complications in 11 Asian countries and regions. Her research team has also used the biobanks of these cohorts and databases to discover the Asian-relevant biogenetic markers for inventions toward precision medicine in diagnosis and classification of diabetes. Under her leadership, The Chinese University of Hong Kong – Prince of Wales Hospital Diabetes Centre has been named as the International Diabetes Federation Centre of Education since 2011 and the International Diabetes Federation Centre of Excellence in Diabetes Care since 2017.

Professor Chan serves on multiple international and regional boards of committees for universities, non-profit organisations and corporations, and is a member respectively for the Grant Review Board of The Research Grants Council and for the Expert Advisory Panel in Primary Healthcare and Non-communicable Disease in Hong Kong. She has published 700 peer-reviewed articles and 26 book chapters over the years and is collaborating with the Monash research team to discover the genetic regulation of cardiovascular disease in type 2 diabetes jointly supported by the National Natural Science Foundation of China and the National Health and Medical Research Council of the Australian Government. From 2016 to 2018, she convened a Lancet Clinical Diabetes Commission comprising 26 global experts from all continents to advocate the use of policies and systems to close the gaps in data, care and outcomes for the lives of many people with or at risk of diabetes and its complications worldwide.